Tandem Diabetes Care Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.17 billion, with shareholders equity totaling $130.39 million.
The company employs approximately 1.043 people and operates in the Health sector, within the Medical Supplies and Equipment industry.
Over the past 12 months, Tandem Diabetes Care Inc. reported $1.04 billion in revenue, generating net income of $-63.32 million.
Key financial metrics include a P/E ratio of -18.43, a price-to-book (P/B) ratio of 8.95, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker TNDM.